114 related articles for article (PubMed ID: 8850240)
1. [Diagnostic and prognostic value of the immunohistochemical study of proliferating cell nuclear antigen (PCNA) expression in paraffin sections from non-hodgkin's lymphoma].
Gómez Arbonés X; Campo Güerri E; Virgili JM; Panades Siurana MJ
Sangre (Barc); 1995 Dec; 40(6):520-1. PubMed ID: 8850240
[No Abstract] [Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.
Hall PA; Levison DA; Woods AL; Yu CC; Kellock DB; Watkins JA; Barnes DM; Gillett CE; Camplejohn R; Dover R
J Pathol; 1990 Dec; 162(4):285-94. PubMed ID: 1981239
[TBL] [Abstract][Full Text] [Related]
3. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.
Ristamäki R; Joensuu H; Söderström KO; Jalkanen S
J Pathol; 1995 Jul; 176(3):259-67. PubMed ID: 7545748
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in archival samples of non-Hodgkin's lymphoma. Correlation with flow cytometry proliferation results.
Gómez-Arbonés X; Mací J; Gallart MA; Campo E; Ramos J
Eur J Haematol; 1996 Apr; 56(4):252-3. PubMed ID: 8641395
[No Abstract] [Full Text] [Related]
5. Primary malignant non-Hodgkin's lymphomas of salivary glands.
Faur A; Lazăr E; Cornianu M; Dema A; Lăzureanu C; Mureşan A; Tăban S
Rom J Morphol Embryol; 2009; 50(4):693-9. PubMed ID: 19942968
[TBL] [Abstract][Full Text] [Related]
6. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
[TBL] [Abstract][Full Text] [Related]
7. Percentage of proliferating cell nuclear antigen (PCNA)-positive Reed-Sternberg cells in nodular sclerosis Hodgkin's disease.
Kordek R; Biernat W; Niewiadomska H; Kupnicka D; Woźniak L; Domagała W; Osborn M
Patol Pol; 1993; 44(3):129-31. PubMed ID: 7902558
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
Klemi PJ; Alanen K; Jalkanen S; Joensuu H
Br J Cancer; 1992 Oct; 66(4):739-43. PubMed ID: 1358164
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas.
Kalmanti M; Kanavaros P; Sakalidou A; Tzardi M; Datseris G; Bolonaki E; Kalmantis T; Kazlaris E; Delides G
Acta Morphol Hung; 1992; 40(1-4):215-21. PubMed ID: 1365765
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
[TBL] [Abstract][Full Text] [Related]
11. Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA).
Ramael M; Jacobs W; Weyler J; Van Meerbeeck J; Białasiewicz P; Van den Bossche J; Buysse C; Vermeire P; Van Marck E
J Pathol; 1994 Mar; 172(3):247-53. PubMed ID: 7910850
[TBL] [Abstract][Full Text] [Related]
12. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
[TBL] [Abstract][Full Text] [Related]
13. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
14. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma.
Lehmann J; Retz M; Nürnberg N; Schnöckel U; Raffenberg U; Krams M; Kellner U; Siemer S; Weichert-Jacobsen K; Stöckle M
Cancer; 2004 Oct; 101(7):1552-62. PubMed ID: 15378494
[TBL] [Abstract][Full Text] [Related]
15. [Possible prognostic role of PCNA in colonic adenomas].
Tranchina MG; Puzzo L
Pathologica; 1993; 85(1100):679-85. PubMed ID: 7909595
[TBL] [Abstract][Full Text] [Related]
16. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
17. P 53 and PCNA in Non Hodgkin's lymphoma--an immunohistochemical evaluation.
Burra U; Shanthi P; Krishnan KB; Madhavan M
Indian J Pathol Microbiol; 2000 Jan; 43(1):61-4. PubMed ID: 12583422
[TBL] [Abstract][Full Text] [Related]
18. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
[TBL] [Abstract][Full Text] [Related]
19. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer metastatic phenotype as predicted by histologic tumor markers.
Heimann R; Ferguson D; Recant WM; Hellman S
Cancer J Sci Am; 1997; 3(4):224-9. PubMed ID: 9263628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
